Americafirst Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Americafirst Capital Management's BMY Position: Q1 2017 in Review
Americafirst Capital Management sold out of Bristol-Myers Squibb (BMY) in Q1 2017, closing a stake of 35,386 shares — an estimated $2.07M sold.
Americafirst Capital Management first reported a position in BMY in Q3 2015 and held it in 2 quarters. The position peaked at $585M in Q3 2015. 1,597 funds tracked by Wall St. Rank hold BMY as of Q1 2017.
- Americafirst Capital Management reported no remaining Bristol-Myers Squibb position as of Q1 2017 after selling out during the quarter.
- Americafirst Capital Management sold 35,386 Bristol-Myers Squibb shares in Q1 2017, an estimated $2.07M.
- Americafirst Capital Management first reported a position in Bristol-Myers Squibb in Q3 2015 and held it in 2 quarters.
- Americafirst Capital Management's Bristol-Myers Squibb position peaked at $585M in Q3 2015.
- 1,597 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2017.
Based on Americafirst Capital Management's 13F filing for Q1 2017, filed 17 Apr 2017.